Finding 1127906 (2024-006)

Significant Deficiency
Requirement
AB
Questioned Costs
-
Year
2024
Accepted
2025-03-31

AI Summary

  • Core Issue: Payroll expenditures were allocated without proper review, as two out of 43 timecards lacked necessary employee and supervisor approvals.
  • Impacted Requirements: Compliance with 2 CFR §200.303 and §200.430, which mandate accurate documentation and internal controls for federal award expenditures.
  • Recommended Follow-Up: Ensure consistent collection and retention of timesheet approvals from employees and supervisors for all pay periods, and implement timely attestations for any missing approvals.

Finding Text

Federal Agencies: Department of the Treasury Federal Assistance Listing Numbers: COVID-19 Coronavirus State and Local Fiscal Recovery Funds Programs: 21.027 Award/Pass-Through Entity Identifying Numbers: HCS-23-AR-2111-018, ARPA - HCS-22-AR-2104-018, COVID-19 - EL-22-AR-27-018, ARPA - EL-22-AR-35-018(1), ARPA - EL-21-AR-03-018(4), ARPA - EL-21-AR-04-018(5), ARPA - EL-22-AR-29-018(2), ARPA - HS-21-AR-01-018(2), BH-22-AR-02-018(1), HCS-23-67-2301-018, HCS-23-AR-2107-018, ARP – 19911, CRF-2024-01, Agreement, 3733, COVID-19 – Agreement, K501, K4893, K4786, K4560, K4862 Criteria: The Uniform Guidance in 2 CFR §200.303 requires that non Federal entities receiving Federal awards (i.e., auditee management) establish and maintain internal control designed to reasonably ensure compliance with Federal statues, regulations, and the terms and conditions of the Federal award. Per 2 CFR §200.430 Compensation – Personal Services: “Standards for Documentation of Personnel Expenses (1) Charges to Federal awards for salaries and wages must be based on records that accurately reflect the work performed. These records must: (i) Be supported by a system of internal control, which provides reasonable assurance that the charges are accurate, allowable, and properly allocated; (ii) Be incorporated into the official records of the non-Federal entity; (iii) Reasonably reflect the total activity for which the employee is compensated by the non-Federal entity, not exceeding 100% of compensated activities; (iv) Encompass federally assisted and all other activities compensated by the non-Federal entity on an integrated basis, but may include the use of subsidiary records as defined in the non Federal entity’s written policy; (v) Comply with the established accounting policies and practices of the non Federal entity; and (vi) [Reserved] (vii) Support the distribution of the employee’s salary or wages among specific activities or cost objectives if the employee works on more than one Federal award; a Federal award and non-Federal award; an indirect cost activity and a direct cost activity; two or more indirect activities, which are allocated using different allocation bases; or an unallowable activity and a direct or indirect cost activity. (viii) Budget estimates (i.e., estimates determined before the services are performed) alone do not qualify as support for charges to Federal awards, but may be used for interim accounting purposes, provided that: (A) The system for establishing the estimates produces reasonable approximations of the activity actually performed; (B) Significant changes in the corresponding work activity (as defined by the non-Federal entity’s written policies) are identified and entered into the records in a timely manner. Short-term (such as one or two months) fluctuation between workload categories need not be considered as long as the distribution of salaries and wages is reasonable over the longer term; and (C) The non-Federal entity’s system of internal controls includes processes to review after the fact interim charges made to a Federal award based on budget estimates. All necessary adjustment must be made such that the final amount charged to the Federal award is accurate, allowable, and properly allocated.” Condition: We noted that the Organization allocated payroll expenditures using timecards that were not fully reviewed and approved. Two out of 43 selections for the Coronavirus State and Local Fiscal Recovery Funds program did not have employee and/or supervisor approvals. Cause: The Organization did not have adequate policies/procedures in place to ensure timesheet allocations are obtained for all employees charging time to federal grants and that they are appropriately reviewed. Effect or Potential Effect: Without adequate controls to ensure that costs allocated to federal programs are supported, the Organization could incorrectly charge expenditures to the federal program. Questioned Costs: None above the $25,000 reporting threshold. Context: This is a condition identified per review of the Organization’s compliance with specified requirements not using a statistically valid sample. Payroll costs charged to the Coronavirus State and Local Fiscal Recovery Funds program were $1,320,137 in fiscal year 2024. Any costs not adequately supported by approved timesheet or subsequent attestation are considered questioned costs. Identification as a Repeat Finding: No similar finding noted in the prior year. Recommendation: The Organization should consistently obtain and retain timesheet approvals from both employees and supervisors for each pay period requested for reimbursement. Subsequent attestations of time worked should be timely obtained if detective controls identify missing timesheet approvals. Views of Responsible Officials: Management agrees with the finding. Management is updating and implementing mitigating controls to ensure approvals are sufficiently documented.

Categories

Allowable Costs / Cost Principles Matching / Level of Effort / Earmarking Subrecipient Monitoring Cash Management Reporting

Other Findings in this Audit

  • 551396 2024-004
    Significant Deficiency Repeat
  • 551397 2024-004
    Significant Deficiency Repeat
  • 551398 2024-004
    Significant Deficiency Repeat
  • 551399 2024-004
    Significant Deficiency Repeat
  • 551400 2024-004
    Significant Deficiency Repeat
  • 551401 2024-004
    Significant Deficiency Repeat
  • 551402 2024-004
    Significant Deficiency Repeat
  • 551403 2024-004
    Significant Deficiency Repeat
  • 551404 2024-004
    Significant Deficiency Repeat
  • 551405 2024-004
    Significant Deficiency Repeat
  • 551406 2024-004
    Significant Deficiency Repeat
  • 551407 2024-004
    Significant Deficiency Repeat
  • 551408 2024-004
    Significant Deficiency Repeat
  • 551409 2024-004
    Significant Deficiency Repeat
  • 551410 2024-004
    Significant Deficiency Repeat
  • 551411 2024-004
    Significant Deficiency Repeat
  • 551412 2024-004
    Significant Deficiency Repeat
  • 551413 2024-004
    Significant Deficiency Repeat
  • 551414 2024-004
    Significant Deficiency Repeat
  • 551415 2024-004
    Significant Deficiency Repeat
  • 551416 2024-004
    Significant Deficiency Repeat
  • 551417 2024-004
    Significant Deficiency Repeat
  • 551418 2024-004
    Significant Deficiency Repeat
  • 551419 2024-004
    Significant Deficiency Repeat
  • 551420 2024-004
    Significant Deficiency Repeat
  • 551421 2024-004
    Significant Deficiency Repeat
  • 551422 2024-005
    Significant Deficiency
  • 551423 2024-005
    Significant Deficiency
  • 551424 2024-005
    Significant Deficiency
  • 551425 2024-005
    Significant Deficiency
  • 551426 2024-005
    Significant Deficiency
  • 551427 2024-005
    Significant Deficiency
  • 551428 2024-005
    Significant Deficiency
  • 551429 2024-005
    Significant Deficiency
  • 551430 2024-005
    Significant Deficiency
  • 551431 2024-005
    Significant Deficiency
  • 551432 2024-005
    Significant Deficiency
  • 551433 2024-005
    Significant Deficiency
  • 551434 2024-005
    Significant Deficiency
  • 551435 2024-005
    Significant Deficiency
  • 551436 2024-005
    Significant Deficiency
  • 551437 2024-005
    Significant Deficiency
  • 551438 2024-005
    Significant Deficiency
  • 551439 2024-005
    Significant Deficiency
  • 551440 2024-005
    Significant Deficiency
  • 551441 2024-005
    Significant Deficiency
  • 551442 2024-005
    Significant Deficiency
  • 551443 2024-005
    Significant Deficiency
  • 551444 2024-006
    Significant Deficiency
  • 551445 2024-006
    Significant Deficiency
  • 551446 2024-006
    Significant Deficiency
  • 551447 2024-006
    Significant Deficiency
  • 551448 2024-006
    Significant Deficiency
  • 551449 2024-006
    Significant Deficiency
  • 551450 2024-006
    Significant Deficiency
  • 551451 2024-006
    Significant Deficiency
  • 551452 2024-006
    Significant Deficiency
  • 551453 2024-006
    Significant Deficiency
  • 551454 2024-006
    Significant Deficiency
  • 551455 2024-006
    Significant Deficiency
  • 551456 2024-006
    Significant Deficiency
  • 551457 2024-006
    Significant Deficiency
  • 551458 2024-006
    Significant Deficiency
  • 551459 2024-006
    Significant Deficiency
  • 551460 2024-006
    Significant Deficiency
  • 551461 2024-006
    Significant Deficiency
  • 551462 2024-006
    Significant Deficiency
  • 551463 2024-006
    Significant Deficiency
  • 551464 2024-006
    Significant Deficiency
  • 1127838 2024-004
    Significant Deficiency Repeat
  • 1127839 2024-004
    Significant Deficiency Repeat
  • 1127840 2024-004
    Significant Deficiency Repeat
  • 1127841 2024-004
    Significant Deficiency Repeat
  • 1127842 2024-004
    Significant Deficiency Repeat
  • 1127843 2024-004
    Significant Deficiency Repeat
  • 1127844 2024-004
    Significant Deficiency Repeat
  • 1127845 2024-004
    Significant Deficiency Repeat
  • 1127846 2024-004
    Significant Deficiency Repeat
  • 1127847 2024-004
    Significant Deficiency Repeat
  • 1127848 2024-004
    Significant Deficiency Repeat
  • 1127849 2024-004
    Significant Deficiency Repeat
  • 1127850 2024-004
    Significant Deficiency Repeat
  • 1127851 2024-004
    Significant Deficiency Repeat
  • 1127852 2024-004
    Significant Deficiency Repeat
  • 1127853 2024-004
    Significant Deficiency Repeat
  • 1127854 2024-004
    Significant Deficiency Repeat
  • 1127855 2024-004
    Significant Deficiency Repeat
  • 1127856 2024-004
    Significant Deficiency Repeat
  • 1127857 2024-004
    Significant Deficiency Repeat
  • 1127858 2024-004
    Significant Deficiency Repeat
  • 1127859 2024-004
    Significant Deficiency Repeat
  • 1127860 2024-004
    Significant Deficiency Repeat
  • 1127861 2024-004
    Significant Deficiency Repeat
  • 1127862 2024-004
    Significant Deficiency Repeat
  • 1127863 2024-004
    Significant Deficiency Repeat
  • 1127864 2024-005
    Significant Deficiency
  • 1127865 2024-005
    Significant Deficiency
  • 1127866 2024-005
    Significant Deficiency
  • 1127867 2024-005
    Significant Deficiency
  • 1127868 2024-005
    Significant Deficiency
  • 1127869 2024-005
    Significant Deficiency
  • 1127870 2024-005
    Significant Deficiency
  • 1127871 2024-005
    Significant Deficiency
  • 1127872 2024-005
    Significant Deficiency
  • 1127873 2024-005
    Significant Deficiency
  • 1127874 2024-005
    Significant Deficiency
  • 1127875 2024-005
    Significant Deficiency
  • 1127876 2024-005
    Significant Deficiency
  • 1127877 2024-005
    Significant Deficiency
  • 1127878 2024-005
    Significant Deficiency
  • 1127879 2024-005
    Significant Deficiency
  • 1127880 2024-005
    Significant Deficiency
  • 1127881 2024-005
    Significant Deficiency
  • 1127882 2024-005
    Significant Deficiency
  • 1127883 2024-005
    Significant Deficiency
  • 1127884 2024-005
    Significant Deficiency
  • 1127885 2024-005
    Significant Deficiency
  • 1127886 2024-006
    Significant Deficiency
  • 1127887 2024-006
    Significant Deficiency
  • 1127888 2024-006
    Significant Deficiency
  • 1127889 2024-006
    Significant Deficiency
  • 1127890 2024-006
    Significant Deficiency
  • 1127891 2024-006
    Significant Deficiency
  • 1127892 2024-006
    Significant Deficiency
  • 1127893 2024-006
    Significant Deficiency
  • 1127894 2024-006
    Significant Deficiency
  • 1127895 2024-006
    Significant Deficiency
  • 1127896 2024-006
    Significant Deficiency
  • 1127897 2024-006
    Significant Deficiency
  • 1127898 2024-006
    Significant Deficiency
  • 1127899 2024-006
    Significant Deficiency
  • 1127900 2024-006
    Significant Deficiency
  • 1127901 2024-006
    Significant Deficiency
  • 1127902 2024-006
    Significant Deficiency
  • 1127903 2024-006
    Significant Deficiency
  • 1127904 2024-006
    Significant Deficiency
  • 1127905 2024-006
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
21.023 Emergency Rental Assistance Program $1.45M
10.569 Emergency Food Assistance Program (food Commodities) $1.32M
93.243 Substance Abuse and Mental Health Services Projects of Regional and National Significance $445,660
14.239 Home Investment Partnerships Program $317,473
93.958 Block Grants for Community Mental Health Services $211,702
93.959 Block Grants for Prevention and Treatment of Substance Abuse $182,900
14.218 Community Development Block Grants/entitlement Grants $157,494
10.182 Pandemic Relief Activities: Local Food Purchase Assistance Cooperative Agreement (lfpa) $154,450
93.137 Community Programs to Improve Minority Health $138,632
10.561 State Administrative Matching Grants for the Supplemental Nutrition Assistance Program $98,731
97.024 Emergency Food and Shelter National Board Program $81,030
10.558 Child and Adult Care Food Program $60,698
10.568 Emergency Food Assistance Program (administrative Costs) $56,541
93.493 Congressional Directives $44,461
93.575 Child Care and Development Block Grant $33,980
93.566 Refugee and Entrant Assistance State/replacement Designee Administered Programs $26,530
21.027 Coronavirus State and Local Fiscal Recovery Funds $20,001
10.187 The Emergency Food Assistance Program (tefap) Commodity Credit Corporation Eligible Recipient Funds $18,891
93.597 Grants to States for Access and Visitation Programs $14,491
14.231 Emergency Solutions Grant Program $4,552
14.228 Community Development Block Grants/state's Program and Non-Entitlement Grants in Hawaii $4,127